For the Patient: USMAVPEM

Similar documents
For the Patient: ULUAVPMB

For the Patient: USMAVNIV

For the Patient: USMAVFIPI

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: Bendamustine Other names: TREANDA

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: Eribulin Other names: HALAVEN

Important safety information to minimise the risk of immune-related adverse reactions

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: ULUAVPMTN

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: Vemurafenib Other names: ZELBORAF

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: LUSCTOP

For the Patient: Mitoxantrone Other names:

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

For the Patient: LUAVPEM

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Fludarabine injection Other names: FLUDARA

Discussing TECENTRIQ (atezolizumab) with your healthcare team

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: Olaparib tablets Other names: LYNPARZA

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: LUAJPC

system to help fight cancer Working with your immune

system to help fight cancer Working with your immune

For the Patient: LUAVNP

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: LUAVPP

Giving appropriate patients another chance to fight OPDIVO

For the Patient: Methotrexate Other names: MTX

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: LUAVPG

ABOUT THIS MEDICATION

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

ABOUT THIS MEDICATION

For the Patient: Lenvatinib Other names: LENVIMA

ABOUT THIS MEDICATION

For the Patient: Everolimus tablets Other names: AFINITOR

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

(sunitinib malate) for Kidney Cancer

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: ACTW Other names: BRAJACTW

For the Patient: GUBEP

For the Patient: GDP-R Other names: LYGDPR

Inlyta (axitinib) for Kidney Cancer

For the Patient: LUSCPE

Eloxatin Oxaliplatin concentrated solution for injection

For the Patient: Sunitinib Other names: SUTENT

For the Patient: GOOVDDCAT

For the Patient: GOOVCATM

For the Patient: LUPUPE

Docetaxel (Taxotere )

What do I need to tell my doctor BEFORE I take this drug?

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

Package leaflet: Information for the patient. Bavencio 20 mg/ml concentrate for solution for infusion avelumab

For the Patient: GOOVCATR

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

MEDICATION GUIDE SUTENT

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

WARNINGS AND PRECAUTIONS - COMBINATION OF OPDIVO AND YERVOY

For the Patient: LULAPERT

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

You should read this leaflet carefully and keep it in a safe place to refer to it later. WHAT IS OPDIVO USED FOR

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

Transcription:

For the Patient: USMAVPEM Other Names: Treatment of Unresectable or Metastatic Melanoma Using Pembrolizumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced PEM = Pembrolizumab ABOUT THIS MEDICATION What is this drug used for? Pembrolizumab (pem broe LIZ ue mab) is a drug that is used to treat a type of skin cancer called melanoma, that has spread to other parts of the body or cannot be removed by surgery. How does this drug work? Pembrolizumab helps your immune system attack and destroy cancer cells. INTENDED BENEFITS Pembrolizumab is being given to destroy and/or limit the growth of melanoma cells. It may improve your current symptoms, and delay or prevent the onset of new ones. TREATMENT SUMMARY How is this drug given? Pembrolizumab will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 30 minutes. You will be treated with pembrolizumab once every 3 weeks. This 3 weeks period is called a cycle. The cycle is repeated as long as you are benefiting from treatment and not having too many side effects. What will happen while I am being treated? A blood test (lab work) and other tests are done before starting each treatment cycle at the time you see your oncologist. The treatment may be interrupted based on your test results and/or side effects. BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 1/8

INSTRUCTIONS FOR THE PATIENT What other drugs or foods can interact with pembrolizumab? Other drugs may interact with pembrolizumab. Check with your doctor or pharmacist before you start or stop taking any other drugs including all prescription and nonprescription medicines, steroids or other medicines that lower your immune response, vitamins, and herbal supplements. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of pembrolizumab. Other important things to know: Before you are given pembrolizumab, talk to your doctor or pharmacist if you: o have an active condition where your immune system attacks your body (autoimmune disease), such as ulcerative colitis, Crohn s disease, lupus, rheumatoid arthritis or sarcoidosis. o take other medicines that make your immune system weak. Examples of these may include steroids, such as prednisone. o had an organ transplant, such as a kidney transplant. o have any other medical conditions. It is very important to tell your doctor immediately if you have, or develop, any of the symptoms listed under Serious Side Effects. Do not try to treat or diagnose symptoms yourself. You may have a transient worsening of disease before the tumour shrinks. Tumour response will be assessed during treatment. Pembrolizumab may damage sperm and may harm the baby if used during pregnancy. You must use birth control while being treated with pembrolizumab and for at least 4 months after your last dose. Tell your doctor right away if you or your partner becomes pregnant. Pembrolizumab may pass into your breast milk. Do not breastfeed during treatment Tell doctors or dentists that you are being treated with pembrolizumab before you receive any treatment from them. BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 2/8

SIDE EFFECTS AND WHAT TO DO ABOUT THEM Pembrolizumab may cause serious immune reactions against your own body (autoimmune) affecting many parts. Are there any risks? Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of as they are directly related to the common actions of the drug in your treatment plan. What is the most important information I should know about SERIOUS SIDE EFFECTS? Pembrolizumab can cause serious side effects in many parts of your body. These side effects are most likely to begin during treatment; however, side effects can show up months after your last treatment with pembrolizumab. Tell your doctor as soon as possible if you have any of serious side effects listed in the table below or your symptoms get worse. Do not try to treat or diagnose symptoms yourself. Getting medical treatment right away may keep the problem from becoming more serious. The following side effects were most frequently reported: Very common (more than 1 in 10 people) diarrhea itching, rash joint pain feeling tired feeling less hungry cough BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 3/8

SERIOUS SIDE EFFECTS Inflammation of the intestines (colitis) diarrhea (loose stools) or more bowel movements than usual. Do not treat the diarrhea yourself. blood or mucus in stools or dark, tarry, sticky stools severe stomach pain (abdominal pain) or tenderness Inflammation of the thyroid gland (hyperthyroidism, hypothyroidism) rapid heart beat weight loss or gain increased sweating hair loss feeling cold constipation or diarrhea your voice gets deeper muscle aches changes in sleep patterns Inflammation of the pituitary gland (hypophysitis, hypopituitarism, including secondary adrenal insufficiency) weight loss increased sweating, hot flashes hair loss (includes facial and pubic) feeling cold headaches that will not go away or unusual headache decreased sex drive vision problems excessive thirst and urination How common is it? BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 4/8

Inflammation of the lungs (pneumonitis) shortness of breath chest pain coughing Problems with muscles back pain spasms weakness muscle pain Skin problems rash dry skin SERIOUS SIDE EFFECTS Problems in other organs (nervous system, eyes) tingling, numbness, lack of energy changes in eyesight dizziness Inflammation of the liver (hepatitis) nausea or vomiting loss of appetite pain on the right side of your stomach yellowing of your skin or the whites of your eyes dark urine bleeding or bruise more easily than normal How common is it? Uncommon (less than 1 in 100 but more than 1 in 1000) BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 5/8

Inflammation of the kidneys (nephritis) changes in the amount or colour of your urine Problems in the pancreas abdominal pain nausea and vomiting SERIOUS SIDE EFFECTS Blood sugar problems (type 1 diabetes mellitus) hunger or thirst a need to urinate more often weight loss Infusion reactions shortness of breath itching or rash dizziness fever wheezing flushing feeling like passing out How common is it? Uncommon (less than 1 in 100 but more than 1 in 1000) Rare (less than 1 in 1000 but more than 1 in 10000) Rare (less than 1 in 1000 but more than 1 in 10000) Rare (less than 1 in 1000 but more than 1 in 10000) BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 6/8

OTHER SIDE EFFECTS Pain or tenderness may occur where the needle was placed. Nausea and vomiting may occur after your treatment. Most people have little or no nausea. How common is it? Very rare BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 7/8 MANAGEMENT Apply cool compresses or soak in cool water for 15-20 minutes several times a day. You may be given a prescription for antinausea drug(s) to take before your treatment and/or at home. It is easier to prevent nausea than treat it once it has occurred, so follow directions closely. o Drink plenty of fluids. o Eat and drink often in small amounts. Try the ideas in Food Choices to Help Control Nausea.* If nausea and vomiting is persistent and you have other symptoms of hepatitis, tell your doctor as soon as possible. (see the table above for serious side effects.) Fever may sometimes occur. Take acetaminophen (e.g., TYLENOL ) every 4-6 hours, to a maximum of 4 g (4000 mg) per day. If you have other symptoms of colitis, tell your doctor as soon as possible. (see the table above for serious side effects.) Constipation may sometimes occur. Exercise if you can. Drink plenty of fluids. Try ideas in Suggestions for Dealing with Constipation.* If you have other symptoms of colitis, tell your doctor as soon as possible. (see the table above for serious side effects.) Headache may sometimes occur. Take acetaminophen (e.g., TYLENOL ) every 4-6 hours if needed, to a maximum of 4 g (4000 mg) per day. If headache is persistent and you have other symptoms of inflammation of glands or Inflammation of the nerves, tell your doctor as soon as possible. (see the table above for serious side effects.)

OTHER SIDE EFFECTS Loss of appetite and weight loss sometimes occur. Tiredness and lack of energy may sometimes occur. Hair loss is rare with pembrolizumab. How common is it? MANAGEMENT Very common Try the ideas in Food Ideas to Help with Decreased Appetite. If loss of appetite is persistent and you have other symptoms of hepatitis, tell your doctor as soon as possible. (see the table above for serious side effects.) Very common Do not drive a car or operate machinery if you are feeling tired. Try the ideas in Your Bank to Energy Savings: Helping People with Cancer Handle Fatigue.* If tiredness is persistent and you have other symptoms of hepatitis or inflammation of glands, tell your doctor as soon as possible. (see the table above for serious side effects.) Rare If hair loss is a problem, refer to For the Patient: Hair Loss Due to Chemotherapy.* *Please ask your oncologist or pharmacist for a copy. If you experience symptoms or changes in your body that have not been described above but worry you, or in any symptoms are severe, contact: at telephone number: BC Cancer Agency Protocol Summary (Patient Version) USMAVPEM 8/8